• Decrease font size
  • Return font size to normal
  • Increase font size
U.S. Department of Health and Human Services

CLIA - Clinical Laboratory Improvement Amendments

  • Print
  • Share
  • E-mail
-
1 to 8 of 8 Results
Document Number K980724
Results per Page

New Searchexport reports to excelExport to Excel | HelpHelp
Document Parent Analyte Analyte Specialty Complexity Effective Date
Roche Diagnostics, cobas c 303  {Tina-quant Beta2-Microglobulin} (serum and plasma)
CR220436 K980724 Beta-2 microglobulin General Immunology MODERATE 12/05/2022
Roche Diagnostics, cobas c 303  {Tina-quant Beta2-Microglobulin} (urine)
CR220436 K980724 Beta-2 microglobulin General Immunology MODERATE 12/05/2022
Roche Diagnostics cobas c 503 analytical unit  {Tina-quant Beta-2-Microglobulin (serum/plasma)} (serum and plasma samples only)
CR200070 K980724 Beta-2 microglobulin General Immunology MODERATE 02/26/2020
Roche Diagnostics cobas c 701 beta-2-microglobulin  
K980724 K980724 Beta-2 microglobulin General Immunology MODERATE 09/14/2011
Roche Diagnostics cobas c 702 beta-2-microglobulin  
K980724 K980724 Beta-2 microglobulin General Immunology MODERATE 09/14/2011
Roche Diagnostics cobas c 502 Analyzer  
K100853 K980724 Beta-2 microglobulin General Immunology MODERATE 01/10/2011
Roche Diagnostics cobas c 311 Analyzer  {Roche Diagnostics Tina-quant b2-microglobulin} 
K980724 K980724 Beta-2 microglobulin General Immunology MODERATE 02/06/2009
Roche Diagnostics cobas c 501 Analyzer  
K980724 K980724 Beta-2 microglobulin General Immunology MODERATE 01/18/2007

-
-